Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Indivior PLC, a global leader in addiction treatment, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2014, the company has rapidly established itself within the pharmaceutical industry, focusing on innovative solutions for opioid dependence and other substance use disorders.
Indivior is renowned for its flagship product, Suboxone, which combines buprenorphine and naloxone to effectively manage opioid addiction while minimising misuse potential. This unique formulation has positioned Indivior as a key player in the market, contributing to significant advancements in addiction therapy.
With a commitment to improving patient outcomes, Indivior has achieved notable milestones, including regulatory approvals and partnerships that enhance its service offerings. The company continues to lead the way in addressing the global opioid crisis, solidifying its reputation as a trusted provider in the addiction treatment sector.
+4 vs industry average
Indivior’s score of 44 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
In 2024, Indivior reported total carbon emissions of approximately 141.5 million kg CO2e, comprising 6,986,000 kg CO2e from Scope 1, 5,174,000 kg CO2e from Scope 2, and 129,350,000 kg CO2e from Scope 3 emissions. This marks a significant increase from 2023, when total emissions were approximately 114.7 million kg CO2e, with Scope 1 emissions at 4,573,000 kg CO2e, Scope 2 at 2,366,000 kg CO2e, and Scope 3 at 107,779,000 kg CO2e.
Indivior has set ambitious climate commitments, aiming for a 100% transition to hybrid vehicles by the end of 2026, which applies to both Scope 1 and Scope 2 emissions. Additionally, the company is optimistic about achieving net-zero emissions by 2050, contingent on a globally coordinated effort towards decarbonisation.
The emissions data is not cascaded from any parent organisation, and all figures are directly reported by Indivior. The company continues to focus on reducing its carbon footprint while navigating the complexities of its operational emissions.
Access structured emission data, company specific factors and auditable source documents
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more